Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.

Influenza vaccine for chronic obstructive pulmonary disease (COPD).

Kopsaftis Z, Wood-Baker R, Poole P.

Cochrane Database Syst Rev. 2018 Jun 26;6:CD002733. doi: 10.1002/14651858.CD002733.pub3. Review.

PMID:
29943802
2.

Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life.

Bui DS, Lodge CJ, Burgess JA, Lowe AJ, Perret J, Bui MQ, Bowatte G, Gurrin L, Johns DP, Thompson BR, Hamilton GS, Frith PA, James AL, Thomas PS, Jarvis D, Svanes C, Russell M, Morrison SC, Feather I, Allen KJ, Wood-Baker R, Hopper J, Giles GG, Abramson MJ, Walters EH, Matheson MC, Dharmage SC.

Lancet Respir Med. 2018 Jul;6(7):535-544. doi: 10.1016/S2213-2600(18)30100-0. Epub 2018 Apr 5.

PMID:
29628376
3.

Childhood measles contributes to post-bronchodilator airflow obstruction in middle-aged adults: A cohort study.

Perret JL, Matheson MC, Gurrin LC, Johns DP, Burgess JA, Thompson BR, Lowe AJ, Markos J, Morrison SS, McDonald CF, Wood-Baker R, Svanes C, Thomas PS, Hopper JL, Giles GG, Abramson MJ, Walters EH, Dharmage SC.

Respirology. 2018 Aug;23(8):780-787. doi: 10.1111/resp.13297. Epub 2018 Mar 20.

PMID:
29560611
4.

Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.

Walters JA, Tan DJ, White CJ, Wood-Baker R.

Cochrane Database Syst Rev. 2018 Mar 19;3:CD006897. doi: 10.1002/14651858.CD006897.pub4. Review.

PMID:
29553157
5.

Traffic related air pollution and development and persistence of asthma and low lung function.

Bowatte G, Lodge CJ, Knibbs LD, Erbas B, Perret JL, Jalaludin B, Morgan GG, Bui DS, Giles GG, Hamilton GS, Wood-Baker R, Thomas P, Thompson BR, Matheson MC, Abramson MJ, Walters EH, Dharmage SC.

Environ Int. 2018 Apr;113:170-176. doi: 10.1016/j.envint.2018.01.028. Epub 2018 Feb 7.

PMID:
29427878
6.

Gefitinib for advanced non-small cell lung cancer.

Sim EH, Yang IA, Wood-Baker R, Bowman RV, Fong KM.

Cochrane Database Syst Rev. 2018 Jan 16;1:CD006847. doi: 10.1002/14651858.CD006847.pub2. Review.

PMID:
29336009
7.

Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed.

Jacobson GA, Raidal S, Hostrup M, Calzetta L, Wood-Baker R, Farber MO, Page CP, Walters EH.

Drug Saf. 2018 May;41(5):441-449. doi: 10.1007/s40264-017-0631-1.

PMID:
29332144
8.

Improved spirometric detection of small airway narrowing: concavity in the expiratory flow-volume curve in people aged over 40 years.

Johns DP, Das A, Toelle BG, Abramson MJ, Marks GB, Wood-Baker R, Walters EH.

Int J Chron Obstruct Pulmon Dis. 2017 Dec 13;12:3567-3577. doi: 10.2147/COPD.S150280. eCollection 2017.

9.

Atopy in people aged 40 years and over: Relation to airflow limitation.

Guevara-Rattray EM, Garden FL, James AL, Wood-Baker R, Abramson MJ, Johns DP, Sonia Buist A, Burney PGJ, Haydn Walters E, Toelle BG, Marks GB.

Clin Exp Allergy. 2017 Dec;47(12):1625-1630. doi: 10.1111/cea.13038. Epub 2017 Nov 2.

10.

Occupational exposures to solvents and metals are associated with fixed airflow obstruction.

Alif SM, Dharmage SC, Benke G, Dennekamp M, Burgess JA, Perret JL, Lodge CJ, Morrison S, Johns DP, Giles GG, Gurrin LC, Thomas PS, Hopper JL, Wood-Baker R, Thompson BR, Feather IH, Vermeulen R, Kromhout H, Walters EH, Abramson MJ, Matheson MC.

Scand J Work Environ Health. 2017 Nov 1;43(6):595-603. doi: 10.5271/sjweh.3662. Epub 2017 Aug 7.

PMID:
28782791
11.

Occupational exposure to pesticides are associated with fixed airflow obstruction in middle-age.

Alif SM, Dharmage SC, Benke G, Dennekamp M, Burgess JA, Perret JL, Lodge CJ, Morrison S, Johns DP, Giles GG, Gurrin LC, Thomas PS, Hopper JL, Wood-Baker R, Thompson BR, Feather IH, Vermeulen R, Kromhout H, Walters EH, Abramson MJ, Matheson MC.

Thorax. 2017 Nov;72(11):990-997. doi: 10.1136/thoraxjnl-2016-209665. Epub 2017 Jul 7.

PMID:
28687678
12.

The Dose-Response Association between Nitrogen Dioxide Exposure and Serum Interleukin-6 Concentrations.

Perret JL, Bowatte G, Lodge CJ, Knibbs LD, Gurrin LC, Kandane-Rathnayake R, Johns DP, Lowe AJ, Burgess JA, Thompson BR, Thomas PS, Wood-Baker R, Morrison S, Giles GG, Marks G, Markos J, Tang MLK, Abramson MJ, Walters EH, Matheson MC, Dharmage SC.

Int J Mol Sci. 2017 May 8;18(5). pii: E1015. doi: 10.3390/ijms18051015.

13.

Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.

Walters JA, Tang JN, Poole P, Wood-Baker R.

Cochrane Database Syst Rev. 2017 Jan 24;1:CD001390. doi: 10.1002/14651858.CD001390.pub4. Review.

PMID:
28116747
14.

Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease.

Howcroft M, Walters EH, Wood-Baker R, Walters JA.

Cochrane Database Syst Rev. 2016 Dec 19;12:CD005074. doi: 10.1002/14651858.CD005074.pub4. Review.

PMID:
27990628
15.

A randomized controlled trial of telephone-mentoring with home-based walking preceding rehabilitation in COPD.

Cameron-Tucker HL, Wood-Baker R, Joseph L, Walters JA, Schüz N, Walters EH.

Int J Chron Obstruct Pulmon Dis. 2016 Aug 25;11:1991-2000. doi: 10.2147/COPD.S109820. eCollection 2016.

16.

Cohort Profile: The Tasmanian Longitudinal Health STUDY (TAHS).

Matheson MC, Abramson MJ, Allen K, Benke G, Burgess JA, Dowty JG, Erbas B, Feather IH, Frith PA, Giles GG, Gurrin LC, Hamilton GS, Hopper JL, James AL, Jenkins MA, Johns DP, Lodge CJ, Lowe AJ, Markos J, Morrison SC, Perret JL, Southey MC, Thomas PS, Thompson BR, Wood-Baker R, Haydn Walters E, Dharmage SC; TAHS investigator group.

Int J Epidemiol. 2017 Apr 1;46(2):407-408i. doi: 10.1093/ije/dyw028. No abstract available.

PMID:
27272183
17.

Mother's smoking and complex lung function of offspring in middle age: A cohort study from childhood.

Perret JL, Walters H, Johns D, Gurrin L, Burgess J, Lowe A, Thompson B, Markos J, Morrison S, Thomas P, McDonald C, Wood-Baker R, Hopper J, Svanes C, Giles G, Abramson M, Matheson M, Dharmage S.

Respirology. 2016 Jul;21(5):911-9. doi: 10.1111/resp.12750. Epub 2016 Mar 11.

18.

Platinum versus non-platinum chemotherapy regimens for small cell lung cancer.

Amarasena IU, Chatterjee S, Walters JA, Wood-Baker R, Fong KM.

Cochrane Database Syst Rev. 2015 Aug 2;(8):CD006849. doi: 10.1002/14651858.CD006849.pub3. Review.

PMID:
26233609
19.

Patient Anxiety and Depression Moderate the Effects of Increased Self-management Knowledge on Physical Activity: A Secondary Analysis of a Randomised Controlled Trial on Health-Mentoring in COPD.

Schüz N, Walters JA, Cameron-Tucker H, Scott J, Wood-Baker R, Walters EH.

COPD. 2015;12(5):502-9. doi: 10.3109/15412555.2014.995289. Epub 2015 Mar 16.

PMID:
25774660
20.

Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population: The cross-sectional BOLD study.

Cooksley NA, Atkinson D, Marks GB, Toelle BG, Reeve D, Johns DP, Abramson MJ, Burton DL, James AL, Wood-Baker R, Walters EH, Buist AS, Maguire GP.

Respirology. 2015 Jul;20(5):766-74. doi: 10.1111/resp.12482. Epub 2015 Feb 22.

21.

An observational study of PM10 and hospital admissions for acute exacerbations of chronic respiratory disease in Tasmania, Australia 1992-2002.

Mészáros D, Markos J, FitzGerald DG, Walters EH, Wood-Baker R.

BMJ Open Respir Res. 2015 Jan 7;2(1):e000063. doi: 10.1136/bmjresp-2014-000063. eCollection 2015.

22.

Indacaterol, a once-daily beta2-agonist, versus twice-daily beta₂-agonists or placebo for chronic obstructive pulmonary disease.

Geake JB, Dabscheck EJ, Wood-Baker R, Cates CJ.

Cochrane Database Syst Rev. 2015 Jan 10;1:CD010139. doi: 10.1002/14651858.CD010139.pub2. Review.

PMID:
25575340
23.

Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.

Walters JA, Tan DJ, White CJ, Wood-Baker R.

Cochrane Database Syst Rev. 2014 Dec 10;(12):CD006897. doi: 10.1002/14651858.CD006897.pub3. Review. Update in: Cochrane Database Syst Rev. 2018 Mar 19;3:CD006897.

PMID:
25491891
24.

Spirometry and regular follow-up do not improve quality of life in children or adolescents with asthma: Cluster randomized controlled trials.

Abramson MJ, Schattner RL, Holton C, Simpson P, Briggs N, Beilby J, Nelson MR, Wood-Baker R, Thien F, Sulaiman ND, Colle ED, Wolfe R, Crockett AJ, Massie RJ.

Pediatr Pulmonol. 2015 Oct;50(10):947-54. doi: 10.1002/ppul.23096. Epub 2014 Sep 8.

PMID:
25200397
25.

Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.

Walters JA, Tan DJ, White CJ, Gibson PG, Wood-Baker R, Walters EH.

Cochrane Database Syst Rev. 2014 Sep 1;(9):CD001288. doi: 10.1002/14651858.CD001288.pub4. Review.

PMID:
25178099
26.

Assessing the performance of two lung age equations on the Australian population: using data from the cross-sectional BOLD-Australia study.

Ivey MA, Johns DP, Stevenson C, Maguire GP, Toelle BG, Marks GB, Abramson MJ, Wood-Baker R.

Nicotine Tob Res. 2014 Dec;16(12):1629-37. doi: 10.1093/ntr/ntu123. Epub 2014 Aug 18.

PMID:
25140044
27.

Australian Idiopathic Pulmonary Fibrosis Registry: vital lessons from a national prospective collaborative project.

Moodley Y, Goh N, Glaspole I, Macansh S, Walters EH, Chapman S, Hopkins P, Reynolds PN, Zappala C, Cooper W, Mahar A, Ellis S, McCormack S, Darbishire W, Wood-Baker R, Corte TJ; Australian IPF Registry Steering Committee.

Respirology. 2014 Oct;19(7):1088-91. doi: 10.1111/resp.12358. Epub 2014 Aug 14.

28.

Cardiovascular effects of methacholine-induced airway obstruction in man.

Sharman JE, Johns DP, Marrone J, Walls J, Wood-Baker R, Walters EH.

J Physiol Pharmacol. 2014 Jun;65(3):401-7.

29.

Chronic disease self-management and exercise in COPD as pulmonary rehabilitation: a randomized controlled trial.

Cameron-Tucker HL, Wood-Baker R, Owen C, Joseph L, Walters EH.

Int J Chron Obstruct Pulmon Dis. 2014 May 19;9:513-23. doi: 10.2147/COPD.S58478. eCollection 2014.

30.

SULT 1A3 single-nucleotide polymorphism and the single dose pharmacokinetics of inhaled salbutamol enantiomers: are some athletes at risk of higher urine levels?

Jacobson GA, Yee KC, Wood-Baker R, Walters EH.

Drug Test Anal. 2015 Feb;7(2):109-13. doi: 10.1002/dta.1645. Epub 2014 Apr 1.

PMID:
24692077
31.

Sudden death in a young male with a recent pneumothorax: a case report.

Geake JB, Ritchey DM, Burke J, Halliday A, Wood-Baker R, Maguire G.

Eur Respir Rev. 2014 Mar 1;23(131):145-7. doi: 10.1183/09059180.00004913. No abstract available.

32.

Effects of telephone health mentoring in community-recruited chronic obstructive pulmonary disease on self-management capacity, quality of life and psychological morbidity: a randomised controlled trial.

Walters J, Cameron-Tucker H, Wills K, Schüz N, Scott J, Robinson A, Nelson M, Turner P, Wood-Baker R, Walters EH.

BMJ Open. 2013 Sep 6;3(9):e003097. doi: 10.1136/bmjopen-2013-003097.

33.

Interstitial lung disease due to fumes from heat-cutting polymer rope.

Sharman P, Wood-Baker R.

Occup Med (Lond). 2013 Sep;63(6):451-3. doi: 10.1093/occmed/kqt082. Epub 2013 Jul 23.

PMID:
23881118
34.

Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational study.

Cheng AC, Holmes M, Irving LB, Brown SG, Waterer GW, Korman TM, Friedman ND, Senanayake S, Dwyer DE, Brady S, Simpson G, Wood-Baker R, Upham J, Paterson D, Jenkins C, Wark P, Kelly PM, Kotsimbos T.

PLoS One. 2013 Jul 16;8(7):e68760. doi: 10.1371/journal.pone.0068760. Print 2013.

35.

Asthma diagnosis and treatment - 1016. Is atopy in people aged 40 and over related to fixed airflow obstruction?

Abramson MJ, Toelle BG, James AL, Wood-Baker R, Burton D, Xuan W, Johns DP, Buist AS, Marks GB.

World Allergy Organ J. 2013 Apr 23;6 Suppl 1:P16. doi: 10.1186/1939-4551-6-S1-P16. Epub 2013 Apr 23. No abstract available.

36.

Recent advances in understanding inflammation and remodeling in the airways in chronic obstructive pulmonary disease.

Sohal SS, Ward C, Danial W, Wood-Baker R, Walters EH.

Expert Rev Respir Med. 2013 Jun;7(3):275-88. doi: 10.1586/ers.13.26. Review.

PMID:
23734649
37.

Changes in airway histone deacetylase2 in smokers and COPD with inhaled corticosteroids: a randomized controlled trial.

Sohal SS, Reid D, Soltani A, Weston S, Muller HK, Wood-Baker R, Walters EH.

PLoS One. 2013 May 22;8(5):e64833. doi: 10.1371/journal.pone.0064833. Print 2013.

38.

Swimming training for asthma in children and adolescents aged 18 years and under.

Beggs S, Foong YC, Le HC, Noor D, Wood-Baker R, Walters JA.

Cochrane Database Syst Rev. 2013 Apr 30;(4):CD009607. doi: 10.1002/14651858.CD009607.pub2. Review.

PMID:
23633375
39.

Swimming training for asthma in children and adolescents aged 18 years and under.

Beggs S, Foong YC, Le HC, Noor D, Wood-Baker R, Walters JA.

Paediatr Respir Rev. 2013 Jun;14(2):96-7. doi: 10.1016/j.prrv.2013.03.002. Epub 2013 Apr 3. Review. No abstract available.

PMID:
23562523
40.

Respiratory symptoms and illness in older Australians: the Burden of Obstructive Lung Disease (BOLD) study.

Toelle BG, Xuan W, Bird TE, Abramson MJ, Atkinson DN, Burton DL, James AL, Jenkins CR, Johns DP, Maguire GP, Musk AW, Walters EH, Wood-Baker R, Hunter ML, Graham BJ, Southwell PJ, Vollmer WM, Buist AS, Marks GB.

Med J Aust. 2013 Feb 18;198(3):144-8.

PMID:
23418694
41.

Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2012: the Influenza Complications Alert Network (FluCAN).

Cheng AC, Brown S, Waterer G, Holmes M, Senenayake S, Friedman ND, Hewagama S, Simpson G, Wark P, Upham J, Korman T, Dwyer D, Wood-Baker R, Irving L, Bowler S, Kotsimbos T, Kelly P.

Commun Dis Intell Q Rep. 2013 Sep 30;37(3):E246-52.

42.

The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age.

Perret JL, Dharmage SC, Matheson MC, Johns DP, Gurrin LC, Burgess JA, Marrone J, Markos J, Morrison S, Feather I, Thomas PS, McDonald CF, Giles GG, Hopper JL, Wood-Baker R, Abramson MJ, Walters EH.

Am J Respir Crit Care Med. 2013 Jan 1;187(1):42-8. doi: 10.1164/rccm.201205-0788OC. Epub 2012 Nov 15.

PMID:
23155143
43.

Entering a world of uncertainty: community nurses' engagement with information and communication technology.

Courtney-Pratt H, Cummings E, Turner P, Cameron-Tucker H, Wood-Baker R, Walters EH, Robinson AL.

Comput Inform Nurs. 2012 Nov;30(11):612-9. doi: 10.1097/NXN.0b013e318266caab.

PMID:
22954896
44.

Clinical diaries in COPD: compliance and utility in predicting acute exacerbations.

Walters EH, Walters J, Wills KE, Robinson A, Wood-Baker R.

Int J Chron Obstruct Pulmon Dis. 2012;7:427-35. doi: 10.2147/COPD.S32222. Epub 2012 Jul 10.

45.

Clinical trial of community nurse mentoring to improve self-management in patients with chronic obstructive pulmonary disease.

Wood-Baker R, Reid D, Robinson A, Walters EH.

Int J Chron Obstruct Pulmon Dis. 2012;7:407-13. doi: 10.2147/COPD.S32220. Epub 2012 Jul 4.

46.

Vessel-associated transforming growth factor-beta1 (TGF-β1) is increased in the bronchial reticular basement membrane in COPD and normal smokers.

Soltani A, Sohal SS, Reid D, Weston S, Wood-Baker R, Walters EH.

PLoS One. 2012;7(6):e39736. doi: 10.1371/journal.pone.0039736. Epub 2012 Jun 29.

47.

Supporting health behaviour change in chronic obstructive pulmonary disease with telephone health-mentoring: insights from a qualitative study.

Walters JA, Cameron-Tucker H, Courtney-Pratt H, Nelson M, Robinson A, Scott J, Turner P, Walters EH, Wood-Baker R.

BMC Fam Pract. 2012 Jun 13;13:55. doi: 10.1186/1471-2296-13-55.

48.

Molecular detection of Haemophilus influenzae in COPD sputum is superior to conventional culturing methods.

Wood-Baker R, Tristram S, Latham R, Haug G, Reid D, Roddam LF.

Br J Biomed Sci. 2012;69(1):37-9. No abstract available.

PMID:
22558805
49.

Cigarette smoke and platelet-activating factor receptor dependent adhesion of Streptococcus pneumoniae to lower airway cells.

Grigg J, Walters H, Sohal SS, Wood-Baker R, Reid DW, Xu CB, Edvinsson L, Morissette MC, Stämpfli MR, Kirwan M, Koh L, Suri R, Mushtaq N.

Thorax. 2012 Oct;67(10):908-13. doi: 10.1136/thoraxjnl-2011-200835. Epub 2012 May 1.

PMID:
22550083
50.

Reticular Basement Membrane Vessels Are Increased in COPD Bronchial Mucosa by Both Factor VIII and Collagen IV Immunostaining and Are Hyperpermeable.

Soltani A, Wood-Baker R, Sohal SS, Muller HK, Reid D, Walters EH.

J Allergy (Cairo). 2012;2012:958383. doi: 10.1155/2012/958383. Epub 2012 Feb 27.

Supplemental Content

Loading ...
Support Center